Gliobastome récidivant
University Hospital Inselspital, Berne
II
2
Surgery followed by adjuvant second-line therapy
CHUV
The primary objective of this randomized trial is to compare survival outcome after surgery followed by adjuvant second-line therapy to no surgery followed by second-line therapy in recurrent glioblastoma. An auxiliary objective to primary objective is to compare the survival outcomes of operated patients to control in the subgroups stratified by extent of resection: incomplete resection vs complete resection.
None